PDE4 inhibitor rolipram dynamically regulates the balance between D1-MSNs and D2-MSNs in the DMS to modulate abnormal "Go" behavior associated with alcohol addiction. - Zhao W; Zhao S; Wang ZQ; Chen XF; Zong FJ; Zhang HT (Acta pharmacologica Sinica, 2026)